Responding to COVID-19

At AmerisourceBergen and through our family of companies, we ensure that crucial medications efficiently, reliably and securely reach their destinations every day. We recognize that our work is essential in advancing the treatment and prevention of COVID-19 and are dedicated to supporting our associates, customers, partners and patients at this critical time for healthcare. 

Addressing COVID-19

Treatment and prevention

We’re committed to being the best partner to support ongoing developments in the treatment and prevention of COVID-19.

Safety of our associates

The health, safety and well-being of our associates is a top priority during this global pandemic.

Business continuity

Our customers rely on us in order to treat and care for their patients which means it is paramount that we ensure any disruptions to our operations do not impact our ability to deliver on our customers’ needs.

Product availability and market disruption

We continue to apply innovation to ensure a stable supply of medicines to sites of care.

Partnerships

Responding to a global pandemic, including planning for the distribution of treatment and prevention therapies for COVID-19, takes a coordinated effort.

AmerisourceBergen Foundation support

In alignment with the Foundation’s mission, grant donations have been deployed to regional, national and global organizations focused on combatting the economic, psychosocial and health challenges resulting from the pandemic.

Supporting our customers and partners

Manufacturer resources

Partnering with manufacturers to navigate COVID-19

Animal health resources

Updates, tools and resources to help you and your business through the Coronavirus pandemic

Thoughts from our CEO

Executive Perspectives

Simple Access to COVID Vaccines Creates Unprecedented Logistical Complexity

Coronavirus Report

The Hill's Steve Clemmons interviews Steve Collis

 

Treatment and Prevention

We’re committed to being the best partner to support ongoing developments in the treatment and prevention of COVID-19.

As of May 2021, nearly

1M

patient antibody courses shipped

Media Statement on Federal Retail Pharmacy Program

With the start of the Federal Retail Pharmacy Program, AmerisourceBergen will formally begin its role as a “network administrator” and place orders with the U.S. Centers for Disease Control and Prevention (CDC) on behalf of an initial set of eligible and qualified Good Neighbor Pharmacy and Elevate Provider Network members in certain areas.

Innomar Strategies Reaches Agreement with the Government of Canada to Support COVID-19 Vaccine Distribution

Update on the distribution of Veklury® (Remdesivir) from Gilead Sciences

AmerisourceBergen is working with U.S. Department of Health and Human Services (HHS) in distributing COVID-19 therapies approved for Emergency Use Authorization (EUA)

AmerisourceBergen Reaches Agreement with CDC to Support Independent Community Pharmacies’ Access to COVID-19 Vaccine


 

Safety of our associates

The health, safety and well-being of our associates is a top priority during this global pandemic. We're supporting our front-line associates during COVID-19 with:
  • Enhanced cleaning protocol including EPA-approved disinfectants and additional support from third-party cleaners
  • Implemented "Wally" the UV disinfection robot in our distribution centers to ensure maximum cleanliness and associate safety
  • Back-up dependent care program
  • Enhanced paid time off policy for associates needing to self-quarantine or care for family members
 

Business continuity

Our customers rely on us in order to treat and care for their patients which means it is paramount that we ensure any disruptions to our operations do not impact our ability to deliver on our customers’ needs.
 

Product availability & market disruption

We continue to apply innovation to ensure a stable supply of medicines to sites of care.

How do allocations work for the pharma supply chain?

Three facts about how distributors are managing in-demand inventory.

Essential Medicines Strategic Stockpile Act of 2020

We are supporting legislation to ensure a stable supply of essential medicines for all Americans.

What I've Learned Leading AmerisourceBergen's COVID-19 Task Force

A letter from Heather Zenk, SVP, Strategic Global Sourcing

“It is better for patients and for the security of the supply chain to maintain inventory at the distributor level, rather than concentrate too many resources at any one site of care. This helps ensure the pharmaceutical supply chain's flexibility and responsiveness.”

Heather Zenk

SVP, Strategic Global Sourcing
 

Partnerships

Responding to a global pandemic, including planning for the distribution of treatment and prevention therapies for COVID-19, takes a coordinated effort. We continue to strengthen our public-private partnerships to support the pharmaceutical supply chain in addressing the COVID crisis.

 

AmerisourceBergen Foundation support

Press Release

AmerisourceBergen Foundation Donates $700,000 to Boys & Girls Clubs of America to Roll Out COVID-19 Vaccine Education Programs Across the U.S. 

April 2021

Press Release

The AmerisourceBergen Foundation Commits Global Support to Aid Communities, Individuals and Associates Impacted by COVID-19 

March 2020


Related Insights

Brand story

Five lessons from the healthcare supply chain's response to COVID-19

Contactless payment card reader

Animal Health

Eight COVID-inspired workflows veterinary practices should keep

MWI Animal Health
AmerisourceBergen
April 2021

Manufacturers

Innovation spotlight: Adding nursing support to at-home clinical trials


AmerisourceBergen
March 2021

Pharmacies

Six tips for pharmacies administering the COVID-19 vaccine

Carla Frehn
Good Neighbor Pharmacy
March 2021

Featured News

Press Release

Innomar Strategies and FedEx Express Canada Begin Distribution of Moderna COVID-19 Vaccine Across Canada

December 2020

Press Release

AmerisourceBergen Reaches Agreement with U. S. Centers for Disease Control and Prevention to Support Independent Retail Pharmacies’ Access to COVID-19 Vaccine

November 2020

Press Release

Chronically Simple App Enhanced to Meet the COVID-19 Challenges of the Medically Vulnerable

April 2020